Health Products

Taro-Docusate Capsules USP 100 mg (2014-04-25)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
230000505Taro-Docusate Capsules USP 100 mg
Recalling Firm
Taro Pharmaceuticals Inc.
130 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Taro Pharmaceuticals Inc.
130 East Drive
Brampton
L6T 1C1
Ontario
CANADA
CapsuleDIN 00716731100 mg

Introduction

Recalled products

Taro-Docusate Capsules USP 100 mg

Reason

Foreign matter identified as inert nitrile rubber was found in a capsule.

Depth of distribution

Retailers in all provinces and territories except Yukon, Northwest Territories, Nunavut, and Prince Edward Island.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime